Lebenthal Global Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Lebenthal Global Advisors's DGX Position: Q3 2026 in Review
Lebenthal Global Advisors increased its Quest Diagnostics (DGX) stake by 4.1% in Q3 2026, buying an estimated $54.6K and bringing the position to 5,979 shares worth $1.39M. The position accounts for 0.19% of the portfolio, ranked #89.
Lebenthal Global Advisors first reported a position in DGX in Q1 2025 and has held it in 7 quarters since. 1,137 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Lebenthal Global Advisors held 5,979 shares of Quest Diagnostics worth $1.39M as of Q3 2026.
- Lebenthal Global Advisors bought 236 Quest Diagnostics shares in Q3 2026, an estimated $54.6K.
- Quest Diagnostics made up 0.19% of Lebenthal Global Advisors's portfolio in Q3 2026, its #89 holding.
- Lebenthal Global Advisors first reported a position in Quest Diagnostics in Q1 2025 and has held it in 7 quarters since.
- 1,137 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Lebenthal Global Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.